BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 8452174)

  • 1. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
    Tassler H
    Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.
    Powers RD
    Am J Med; 1993 Mar; 94(3A):155S-158S. PubMed ID: 8452173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.
    Smith JW; Nichols RL
    Am J Med; 1993 Mar; 94(3A):150S-154S. PubMed ID: 8452172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fleroxacin versus amoxicillin in the treatment of acute exacerbation of chronic bronchitis.
    Ulmer W
    Am J Med; 1993 Mar; 94(3A):136S-141S. PubMed ID: 8452170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
    Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis.
    Chodosh S
    Am J Med; 1993 Mar; 94(3A):131S-135S. PubMed ID: 8452169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
    Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of oral fleroxacin given once daily in patients with bone and joint infections.
    Putz PA
    Am J Med; 1993 Mar; 94(3A):177S-181S. PubMed ID: 8452177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fleroxacin and amoxicillin in the treatment of uncomplicated urinary tract infections in women.
    Whitby M; Brown P; Silagy C; Rana C
    Am J Med; 1993 Mar; 94(3A):97S-100S. PubMed ID: 8452191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis.
    Dubois J; Saint-Pierre C; Tremblay C
    Ear Nose Throat J; 1993 Dec; 72(12):804-10. PubMed ID: 8313865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.
    Hyslop DL; Jacobson K; Guerra FJ
    Clin Ther; 1992; 14(2):254-67. PubMed ID: 1611648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic antimicrobial therapy for skin and skin structure infections: comparison of fleroxacin and ceftazidime.
    Parish LC; Jungkind DL
    Am J Med; 1993 Mar; 94(3A):166S-173S. PubMed ID: 8452175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study.
    Pummer K
    Am J Med; 1993 Mar; 94(3A):108S-113S. PubMed ID: 8452165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
    Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
    Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
    Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute bacterial diarrhea: a multicenter international trial comparing placebo with fleroxacin given as a single dose or once daily for 3 days.
    Butler T; Lolekha S; Rasidi C; Kadio A; del Rosal PL; Iskandar H; Rubinstein E; Pastore G
    Am J Med; 1993 Mar; 94(3A):187S-194S. PubMed ID: 8452179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
    Khajotia RR; Vetter N; Harazin H
    Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous fleroxacin versus ceftazidime for lower respiratory tract and skin and soft-tissue infections.
    Huston MJ; Lentino JR
    Clin Ther; 1992; 14(4):595-602. PubMed ID: 1525793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of uncomplicated urinary tract infections. Effectiveness and tolerance of sultamicillin compared with amoxicillin/clavulanic acid].
    Schütz W
    Fortschr Med; 1990 Jun; 108(18):365-8. PubMed ID: 2198211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.